|
Neoplasia
Citations 1-10 of 4217 total displayed.
|
Most recent content
(26 Feb 2009):
|
Blood diffusion and Th1-suppressive effects of galectin-9–containing exosomes released by Epstein-Barr virus–infected nasopharyngeal carcinoma cells
- Jihène Klibi, Toshiro Niki, Alexander Riedel, Catherine Pioche-Durieu, Sylvie Souquere, Eric Rubinstein, Sylvestre Le Moulec, Joël Guigay, Mitsuomi Hirashima, Fethi Guemira, Dinesh Adhikary, Josef Mautner, and Pierre Busson
Blood 2009; 113: 1957-1966.
[Abstract]
[Full text]
[PDF]
|
Past content
(since Jan 1997):
|
Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab
- Farrukh T. Awan, Neil E. Kay, Melanie E. Davis, Wenting Wu, Susan M. Geyer, Nelson Leung, Diane F. Jelinek, Renee C. Tschumper, Charla R. Secreto, Thomas S. Lin, Michael R. Grever, Tait D. Shanafelt, Clive S. Zent, Timothy G. Call, Nyla A. Heerema, Gerard Lozanski, John C. Byrd, and David M. Lucas
Blood 2009; 113: 535-537.
[Abstract]
[Full text]
[PDF]
Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia
- Sarah Cooley, Elizabeth Trachtenberg, Tracy L. Bergemann, Koy Saeteurn, John Klein, Chap T. Le, Steven G. E. Marsh, Lisbeth A. Guethlein, Peter Parham, Jeffrey S. Miller, and Daniel J. Weisdorf
Blood 2009; 113: 726-732.
[Abstract]
[Full text]
[PDF]
Phase I study of obatoclax mesylate (GX15-070), a small molecule pan–Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia
- Susan M. O'Brien, David F. Claxton, Michael Crump, Stefan Faderl, Thomas Kipps, Michael J. Keating, Jean Viallet, and Bruce D. Cheson
Blood 2009; 113: 299-305.
[Abstract]
[Full text]
[PDF]
Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study
- Massimo Di Nicola, Roberta Zappasodi, Carmelo Carlo-Stella, Roberta Mortarini, Serenella M. Pupa, Michele Magni, Liliana Devizzi, Paola Matteucci, Paola Baldassari, Fernando Ravagnani, Antonello Cabras, Andrea Anichini, and Alessandro M. Gianni
Blood 2009; 113: 18-27.
[Abstract]
[Full text]
[PDF]
Stem cell concepts renew cancer research
- John E. Dick
Blood 2008; 112: 4793-4807.
[Abstract]
[Full text]
[PDF]
Translation of the Philadelphia chromosome into therapy for CML
- Brian J. Druker
Blood 2008; 112: 4808-4817.
[Abstract]
[Full text]
[PDF]
Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study
- Gilles Salles, Nicolas Mounier, Sophie de Guibert, Franck Morschhauser, Chantal Doyen, Jean-François Rossi, Corinne Haioun, Pauline Brice, Béatrice Mahé, Reda Bouabdallah, Bruno Audhuy, Christophe Ferme, Caroline Dartigeas, Pierre Feugier, Catherine Sebban, Luc Xerri, and Charles Foussard
Blood 2008; 112: 4824-4831.
[Abstract]
[Full text]
[PDF]
Pharmacokinetics, pharmacodynamics, efficacy, and safety of a new recombinant asparaginase preparation in children with previously untreated acute lymphoblastic leukemia: a randomized phase 2 clinical trial
- Rob Pieters, Inge Appel, Hans-Juergen Kuehnel, Iris Tetzlaff-Fohr, Uwe Pichlmeier, Inekee van der Vaart, Eline Visser, and Rolinda Stigter
Blood 2008; 112: 4832-4838.
[Abstract]
[Full text]
[PDF]
Characteristics and outcome of chronic myeloid leukemia patients with F317L BCR-ABL kinase domain mutation after therapy with tyrosine kinase inhibitors
- Elias Jabbour, Hagop M. Kantarjian, Dan Jones, Neeli Reddy, Susan O'Brien, Guillermo Garcia-Manero, Jan Burger, and Jorge Cortes
Blood 2008; 112: 4839-4842.
[Abstract]
[Full text]
[PDF]
|
|
